Personalized therapeutic approaches for the treatment of chronic lymphocytic leukemia (CLL), guided by shared decision-making, can improve outcomes by aligning treatment with a patient's unique clinical profile, preferences and goals. The Association of Cancer Care Centers (ACCC) is dedicated to providing up-to-date information on CLL management and treatment strategies. In this episode, CANCER BUZZ speaks with Christopher Nelson, ACNP, MBA, certified oncology nurse practitioner at Avera Medical Group Oncology & Hematology, to explore the importance of shared decision-making and patient communication in CLL. Additionally, CANCER BUZZ speaks with Meghan McGrath, MSN, RN, AGACNP, clinical trial nurse navigator at The Leukemia and Lymphoma Society (LLS), who discusses ways to incorporate clinical trials in the shared decision-making process and LLS services that are available to support patients and providers.
"You do what the patient feels is best, you know, you look at what their values are and what's important to them, and then you try to find a therapy that fits those." – Christopher Nelson, ACNP
"I think it's really important to try and make every patient aware of the fact that a clinical trial could be right for them at any stage in the game." – Meghan McGrath, MSN, RN, AGACNP
Christopher Nelson, ACNP
Oncology Nurse Practitioner
Avera Medical Group Oncology & Hematology
Aberdeen, SD
Meghan McGrath, MSN, RN, AGACNP
Clinical Trial Nurse Navigator
The Leukemia and Lymphoma Society (LLS)
Resources:
· ACCC Treatment for Double-Exposed CLL - https://bit.ly/4iSmfV1
· ACCC CLL Resources - https://bit.ly/3E4QqZK
· LLS Clinical Trial Support Center - https://bit.ly/42sqGQk
